• SPX
  • $5,762.48
  • 0.42 %
  • $24.31
  • DJI
  • $42,330.15
  • 0.04 %
  • $17.15
  • N225
  • $38,635.44
  • 1.89 %
  • $715.96
  • FTSE
  • $8,236.95
  • -1.01 %
  • -$83.81
  • IXIC
  • $18,189.17
  • 0.38 %
  • $69.58
Kala Pharmaceuticals, Inc. (KALA) Competitors

Kala Pharmaceuticals, Inc. (KALA) Competitors

NASDAQ Currency in USD Disclaimer

Stock Price

$5.63

$0.28

(5.17%)

Day's range
$5.39
Day's range
$5.67

Kala Pharmaceuticals, Inc. Competitors

Symbol Company Share Price Market Cap P/E Ratio Employee Count Revenue
ADMP
Adamis Pharmaceuticals Corporation $0.78 $7.25 M -0.08 11 $4.76 M
AKAN
Akanda Corp. $1.15 $4.26 M -0.01 46 $2.16 M
ALIM
Alimera Sciences, Inc. $5.54 $157.69 M -12.04 154 $80.75 M
ALKS
Alkermes plc $28.00 $4.05 B 7.12 2100 $1.66 B
BFRI
Biofrontera Inc. $1.32 $5.04 M -0.1 83 $34.07 M
CPHI
China Pharma Holdings, Inc. $0.24 $4.27 M -0.29 231 $7.01 M
DCPH
Deciphera Pharmaceuticals, Inc. $25.59 $2.21 B -11.57 355 $163.36 M
DERM
Journey Medical Corporation $5.62 $94.06 M -27.65 41 $79.18 M
DVAX
Dynavax Technologies Corporation $11.14 $1.58 B 172.29 408 $232.28 M
GHSI
Guardion Health Sciences, Inc. $5.69 $12.71 M -2.47 9 $12.25 M
ITCI
Intra-Cellular Therapies, Inc. $73.12 $7.22 B -58.97 610 $462.18 M
LFCR
Lifecore Biomedical, Inc. $4.92 $180.53 M -2.76 524 $128.26 M
LSDI
Lucy Scientific Discovery Inc. $0.51 $1.42 M -0.11 2 $7,048
MNK
Mallinckrodt plc $0.34 $4.52 M -0.44 2673 $2.21 B
NBIX
Neurocrine Biosciences, Inc. $115.20 $13.58 B 36.58 1500 $1.89 B
ORGO
Organogenesis Holdings Inc. $2.87 $364.57 M 68.75 862 $433.14 M
SHPH
Shuttle Pharmaceuticals Holdings, Inc. $1.31 $7.81 M -0.99 8 $0
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.